Press "esc" to clear
Go to Advanced Search

Showing results

110 of 231
Texas_Biomed_macropinocytosis_graphic-Final.jpg

Article ID: 698671

New Research Pinpoints Pathways Ebola Virus Uses to Enter Cells

Texas Biomedical Research Institute

A new study at Texas Biomedical Research Institute is shedding light on the role of specific proteins that trigger a mechanism allowing Ebola virus to enter cells to establish replication.

Released:
8-Aug-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698593

Novel Vaccine Approach Proves Powerful Against Zika Virus

Ohio State University

A uniquely designed experimental vaccine against Zika virus has proven powerful in mice, new research has found.

Released:
6-Aug-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
photo_4.jpg

Article ID: 698417

Ebola Virus - Subject Matter Experts

Georgetown University Medical Center

WASHINGTON — Georgetown University professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola. Topics include infectious disease control and treatment, vaccine development, clinical trials, global health security, and international health regulations. To schedule an interview, please contact Karen Teber at km463@georgetown.

Released:
1-Aug-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
CroweLab2018SU1_edited-1.jpg

Article ID: 698263

Vanderbilt Team Finds Potent Antibodies Against Three Ebola Viruses

Vanderbilt University Medical Center

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

Released:
30-Jul-2018 3:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697772

Scientists get first look at T cell responses in Ebola virus survivors

Scripps Research Institute

New Scripps Research study offers guidance for more effective Ebola vaccines

Released:
23-Jul-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
BatesPNASEbolavirusparticlesredonalargercellNIH.jpg

Article ID: 696615

Proteins Found in Semen Increase the Spread of Ebola Virus Infection

Perelman School of Medicine at the University of Pennsylvania

Protein fragments, called amyloid fibrils, in human semen significantly increase Ebola virus infection and protect the virus against harsh environmental conditions such as heat and dehydration. Follow-up studies from the 2014 epidemic found that men can harbor the virus in their semen for at least 2.5 years, with the potential to transmit the virus sexually during that time. Targeting amyloids in semen may prevent a sexually transmitted spread of the Ebola virus.

Released:
25-Jun-2018 3:50 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
217123_Rimoin.use.jpg

Article ID: 694909

Ebola in the Congo – UCLA Expert Available

University of California, Los Angeles (UCLA), Health Sciences

Released:
21-May-2018 7:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
photo_4.jpg

Article ID: 694730

Ebola Virus - Subject Matter Experts at Georgetown

Georgetown University Medical Center

Released:
17-May-2018 8:55 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
hemo-virus-vaccine-large.jpg

Article ID: 694538

Vaccine-Induced Antibodies Against One Hemorrhagic Fever Virus Found to Disarm Related Virus for Which There Is No Vaccine

Harvard Medical School

Research conducted in vitro shows two human antibodies made in response to vaccination against one hemorrhagic fever virus can disarm a related virus, for which there is currently no vaccine. The proof-of-principle finding identifies a common molecular chink in the two viruses’ armor that renders both vulnerable to the same antibodies. The results set the stage for a single vaccine and other antibody-based treatments that work against multiple viral “cousins” despite key differences in their genetic makeup. Such therapies can alleviate challenges posed by current lack of vaccines and prevent outbreaks of viral hemorrhagic fevers.

Released:
14-May-2018 2:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Ebola.jpg

Article ID: 694529

Mapping the Body’s Battle with Ebola and Zika

Los Alamos National Laboratory

The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host’s cells.

Released:
14-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 231





Chat now!